Caption Management’s Zura Bio ZURA Stock Holding History

Caption Management’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-99,500	Closed	-$249K	–	2126
2024 Q4	$249K	Sell	99,500 -63,000	-39%	-$224K	﹤0.01%	1235
2024 Q3	$660K	Buy	+162,500	New	+$607K	0.01%	877

Other funds holding ZURA

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Caption Management's ZURA Position: Q1 2026 in Review

Caption Management sold out of Zura Bio (ZURA) in Q1 2026, closing a stake of 155,936 shares — an estimated $817K sold.

Caption Management first reported a position in ZURA in Q3 2024 and held it in 3 quarters. The position peaked at $817K in Q4 2025. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Caption Management reported no remaining Zura Bio position as of Q1 2026 after selling out during the quarter.
Caption Management sold 155,936 Zura Bio shares in Q1 2026, an estimated $817K.
Caption Management first reported a position in Zura Bio in Q3 2024 and held it in 3 quarters.
Caption Management's Zura Bio position peaked at $817K in Q4 2025.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.